The efficacy and safety characteristics of long-term pregabalin treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: Findings from an open-label trial

被引：0

作者：

D'Urso-De Cruz, E

Dworkin, R

Stacey, B

Siffert, J

Fukui, A

Emir, B

机构：

[1] Pfizer Inc, Pfizer Global Pharmaceut, New York, NY USA

[2] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY USA

[3] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA

[4] Pfizer Australia, Pfizer Global Pharmaceut, Sydney, NSW, Australia

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S497 / S498

页数：2

共 50 条

[1] Treatment of neuropathic pain (NeP) associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN) in treatment-refractory patients: Findings from a long-term open-label trial of pregabalin
De Cruz, E. D'Urso
Dworkin, R. H.
Stacey, B.
Siffert, J.
Emir, B.
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 196 - 196
[2] Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy (DPN): Findings from open-label extension studies
Freeman, Roy
D'Urso-Decruz, Edith
Murphy, T. Kevin
Emir, Birol
DIABETES, 2008, 57 : A151 - A151
[3] Pregabalin as treatment for neuropathic pain associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN): Efficacy, safety, and tolerability findings from the analysis of 10 randomized, placebo-controlled clinical trials
Griesing, T
Young, J
LaMoreaux, L
Emir, B
Sharma, U
EPILEPSIA, 2005, 46 : 186 - 187
[4] Long-term treatment of painful DPN and PHN with pregabalin in treatment-refractory patients
De Cruz, ED
Dworkin, R
Stacey, B
Siffert, J
Emir, B
DIABETES, 2005, 54 : A139 - A139
[5] The efficacy, safety, and tolerability of pregabalin treatment for neuropathic pain associated with diabetic peripheral neuropathy or postherpetic neuralgia: Findings from the analysis of 10 randomized clinical trials
Sharma, U
Young, J
LaMoreaux, L
Emir, B
Murphy, TK
Sant, M
Siffert, J
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S501 - S502
[6] Sustained, long-term efficacy of pregabalin as treatment of neuropathic pain associated with diabetic peripheral neuropathy and post-herpetic neuralgia
Portenoy, R.
Sharma, U.
Young, J.
LaMoreaux, L.
Chartier, K.
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 137 - 137
[7] Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy: findings from 7 open-label extension studies
Murphy, K.
Emir, B.
DIABETOLOGIA, 2008, 51 : S503 - S503
[8] Pregabalin sustains its efficacy as long-term maintenance therapy for neuropathic pain associated with diabetic neuropathy and postherpetic neuralgia
Portenoy, R
Sharma, U
Young, J
Lamoreaux, L
Chartier, K
DIABETES, 2004, 53 : A142 - A142
[9] Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients
Siffert, J
Dworkin, RH
Sharma, U
Stacey, B
Chambers, R
NEUROLOGY, 2005, 64 (06) : A121 - A122
[10] Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia:: Open-label, non-comparative, flexible-dose study
Baron, Ralf
Brunnmueller, Ulrike
Brasser, Matthias
May, Michael
Binder, Andreas
EUROPEAN JOURNAL OF PAIN, 2008, 12 (07) : 850 - 858

← 1 2 3 4 5 →